September 12, 2026

News, minutes after it breaks

Latest

Home  / Business

FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients

Image: CNBC

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.

CNBC reported this story. Read the full report on cnbc.com →

This is a short summary. CNBC wrote and published the full report.

Continue on cnbc.com →

More in Business

Leave a Reply

Your email address will not be published. Required fields are marked *